RT info:eu-repo/semantics/article
T1 Progress in wound-healing products based on natural compounds, stem cells, and microRNA-based biopolymers in the European, USA, and Asian markets: opportunities, barriers, and regulatory issues
A1 Srivastava, Girish Kumar
A1 Martínez Rodríguez, Sofía
A1 Md Fadilah, Nur Izzah
A1 Looi Qi Hao, Daniel
A1 Markey, Gavin
A1 Shukla, Priyank
A1 Fauzi, Mh Busra
A1 Panetsos, Fivos
K1 Dermatology
K1 Wounds and injuries - Treatment
K1 Heridas y lesiones - Tratamiento
K1 Skin - Diseases
K1 Piel - Enfermedades
K1 Natural products
K1 Productos naturales
K1 Biopolymers
K1 Biopolímeros
K1 Stem cells
K1 Células madre
K1 Calidad - Control - Normas
K1 ISO - Normas
K1 Quality control
K1 Medical technology
K1 32 Ciencias Médicas
K1 3201.06 Dermatología
K1 3314 Tecnología Médica
K1 
AB Wounds are breaks in the continuity of the skin and underlying tissues, resulting from external causes such as cuts, blows, impacts, or surgical interventions. Countless individuals suffer minor to severe injuries, with unfortunate cases even leading to death. In today’s scenario, several commercial products are available to facilitate the healing process of wounds, although chronic wounds still present more challenges than acute wounds. Nevertheless, the huge demand for wound-care products within the healthcare sector has given rise to a rapidly growing market, fostering continuous research and development endeavors for innovative wound-healing solutions. Today, there are many commercially available products including those based on natural biopolymers, stem cells, and microRNAs that promote healing from wounds. This article explores the recent breakthroughs in wound-healing products that harness the potential of natural biopolymers, stem cells, and microRNAs. A comprehensive exploration is undertaken, covering not only commercially available products but also those still in the research phase. Additionally, we provide a thorough examination of the opportunities, obstacles, and regulatory considerations influencing the potential commercialization of wound-healing products across the diverse markets of Europe, America, and Asia.
PB MDPI
SN 2073-4360
YR 2024
FD 2024
LK https://uvadoc.uva.es/handle/10324/68134
UL https://uvadoc.uva.es/handle/10324/68134
LA eng
NO Polymers, 2024, Vol. 16, Nº. 9, 1280
NO Producción Científica
DS UVaDOC
RD 08-ene-2025